Company intelligence / Profile preview

Shenzhen Yixin Kang Biotechnology

Shenzhen, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Shenzhen Yixinkang Biotechnology Co., Ltd. is a clinical-stage Chinese biotechnology company focused on developing innovative peptide-based therapeutics for inflammatory, autoimmune, and ophthalmic diseases. The company's lead candidate is Epivotide (ipiluvitide), a first-in-class synthetic peptide inhibitor targeting the PIK3R3 (p55PIK) regulatory subunit of phosphatidylinositol 3-kinase (PI3K). Epivotide is currently being evaluated in Phase 2 clinical trials for several indications, including neurotrophic keratitis, dry eye syndrome, and perennial allergic rhinitis. Shenzhen Yixinkang Biotechnology operates in close affiliation with Wuhan Yicheng Biotechnology and Yicheng Kangtai (Xiamen) Biotechnology, sharing leadership under founder Dr. Xia Xianmin to advance its pipeline of targeted anti-inflammatory therapies.

Therapeutic areas: OphthalmologyDermatologyImmunology
Modalities: Synthetic peptideBiologic
Industry: Biotech

Beyond the preview

Go deeper on Shenzhen Yixin Kang Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenzhen Yixin Kang Biotechnology.

Explore the full profile